FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

Project Oncology® - En podcast av ReachMD

Prova Storytel gratis i 30 dagar nu!

Ett universum fyllt av ljudböcker, klicka här för att komma igång

Kategorier:

FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma. Released May 22, 2017

Visit the podcast's native language site